Homozygous mutation at cytochrome P4502D6 in an individual with schizophrenia

Implications for antipsychotic drugs, side effects and compliance

Michael Gill, Ziarih Hawi, Marcus Webb

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)

Abstract

We report the case of a patient with schizophrenia who has suffered severe side effects with many different antipsychotics. She is poorly compliant with treatment probably because of her experiences with medication. We determined her genotype at the CYP2D6 gene that codes for an enzyme principally involved in the metabolism of many antipsychotics. She was homozygous for the 'B' mutation, the most frequent of several known mutations. She therefore has no functioning CYP2D6 enzyme in common with 5%-10% of the population. This may explain why she is sensitive to quite moderate doses of antipsychotic medication, and more rational prescribing may lead to fewer side effects and increased compliance.

Original languageEnglish
Pages (from-to)38-39
Number of pages2
JournalIrish Journal of Psychological Medicine
Volume14
Issue number1
Publication statusPublished - 1997
Externally publishedYes

Keywords

  • antipsychotic drugs
  • CYP2D6
  • cytochrome P450
  • genetics
  • side effects

Cite this

@article{6111c75969cf4438b5ba3e1a58968752,
title = "Homozygous mutation at cytochrome P4502D6 in an individual with schizophrenia: Implications for antipsychotic drugs, side effects and compliance",
abstract = "We report the case of a patient with schizophrenia who has suffered severe side effects with many different antipsychotics. She is poorly compliant with treatment probably because of her experiences with medication. We determined her genotype at the CYP2D6 gene that codes for an enzyme principally involved in the metabolism of many antipsychotics. She was homozygous for the 'B' mutation, the most frequent of several known mutations. She therefore has no functioning CYP2D6 enzyme in common with 5{\%}-10{\%} of the population. This may explain why she is sensitive to quite moderate doses of antipsychotic medication, and more rational prescribing may lead to fewer side effects and increased compliance.",
keywords = "antipsychotic drugs, CYP2D6, cytochrome P450, genetics, side effects",
author = "Michael Gill and Ziarih Hawi and Marcus Webb",
year = "1997",
language = "English",
volume = "14",
pages = "38--39",
journal = "Irish Journal of Psychological Medicine",
issn = "0790-9667",
publisher = "Cambridge University Press",
number = "1",

}

Homozygous mutation at cytochrome P4502D6 in an individual with schizophrenia : Implications for antipsychotic drugs, side effects and compliance. / Gill, Michael; Hawi, Ziarih; Webb, Marcus.

In: Irish Journal of Psychological Medicine, Vol. 14, No. 1, 1997, p. 38-39.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Homozygous mutation at cytochrome P4502D6 in an individual with schizophrenia

T2 - Implications for antipsychotic drugs, side effects and compliance

AU - Gill, Michael

AU - Hawi, Ziarih

AU - Webb, Marcus

PY - 1997

Y1 - 1997

N2 - We report the case of a patient with schizophrenia who has suffered severe side effects with many different antipsychotics. She is poorly compliant with treatment probably because of her experiences with medication. We determined her genotype at the CYP2D6 gene that codes for an enzyme principally involved in the metabolism of many antipsychotics. She was homozygous for the 'B' mutation, the most frequent of several known mutations. She therefore has no functioning CYP2D6 enzyme in common with 5%-10% of the population. This may explain why she is sensitive to quite moderate doses of antipsychotic medication, and more rational prescribing may lead to fewer side effects and increased compliance.

AB - We report the case of a patient with schizophrenia who has suffered severe side effects with many different antipsychotics. She is poorly compliant with treatment probably because of her experiences with medication. We determined her genotype at the CYP2D6 gene that codes for an enzyme principally involved in the metabolism of many antipsychotics. She was homozygous for the 'B' mutation, the most frequent of several known mutations. She therefore has no functioning CYP2D6 enzyme in common with 5%-10% of the population. This may explain why she is sensitive to quite moderate doses of antipsychotic medication, and more rational prescribing may lead to fewer side effects and increased compliance.

KW - antipsychotic drugs

KW - CYP2D6

KW - cytochrome P450

KW - genetics

KW - side effects

UR - http://www.scopus.com/inward/record.url?scp=0030891523&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 38

EP - 39

JO - Irish Journal of Psychological Medicine

JF - Irish Journal of Psychological Medicine

SN - 0790-9667

IS - 1

ER -